1. Home
  2. PCSA vs FAMI Comparison

PCSA vs FAMI Comparison

Compare PCSA & FAMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Processa Pharmaceuticals Inc.

PCSA

Processa Pharmaceuticals Inc.

HOLD

Current Price

$2.13

Market Cap

8.0M

Sector

Health Care

ML Signal

HOLD

Logo Farmmi Inc.

FAMI

Farmmi Inc.

HOLD

Current Price

$1.38

Market Cap

7.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCSA
FAMI
Founded
2011
2015
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
8.0M
7.8M
IPO Year
2012
2017

Fundamental Metrics

Financial Performance
Metric
PCSA
FAMI
Price
$2.13
$1.38
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$25.00
N/A
AVG Volume (30 Days)
45.4K
7.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
54.36
N/A
EPS
N/A
N/A
Revenue
$5,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$0.14
52 Week High
$8.88
$2.22

Technical Indicators

Market Signals
Indicator
PCSA
FAMI
Relative Strength Index (RSI) 47.08 55.74
Support Level $0.21 $1.23
Resistance Level $2.56 $1.57
Average True Range (ATR) 0.21 0.07
MACD 0.01 0.01
Stochastic Oscillator 63.75 100.00

Price Performance

Historical Comparison
PCSA
FAMI

About PCSA Processa Pharmaceuticals Inc.

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The three NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem), and PCS11T, also referred to as NGC-Irinotecan (NGC-Iri).

About FAMI Farmmi Inc.

Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe, and the Middle East under the Forasen and Farmmi brands.

Share on Social Networks: